Julie Papanek serves as Executive at Protagonist Therapeutics, Inc, where they oversee executive responsibilities. Since joining the company, Julie Papanek has executed 2 insider transactions totaling $7.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 16, 2016 involved purchasing 583,333 shares valued at $7.0M.
Julie Papanek currently holds 2,453,255 shares of Protagonist Therapeutics, Inc (PTGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Julie Papanek has been a net buyer of PTGX stock. They have purchased $7.0M and sold $0 worth of shares.
Julie Papanek's most recent insider trade was on Aug 16, 2016, when they purchased 583,333 shares at $12.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |